Aerie Pharmaceuticals, Inc. (AERI) financial statements (2021 and earlier)

Company profile

Business Address 4301 EMPEROR BOULEVARD
DURHAM, NC 27703
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:240218242265309346109
Cash and cash equivalents152130151134144249109
Short-term investments89899113116592 
Other undisclosed cash, cash equivalents, and short-term investments     5 
Receivables56474343383326
Inventory, net of allowances, customer advances and progress billings27211920211510
Inventory27211920211510
Other undisclosed current assets89911839
Total current assets:332295313338376397154
Noncurrent Assets
Operating lease, right-of-use asset14151515171718
Property, plant and equipment54555657585859
Long-term investments and receivables     5 
Long-term investments     5 
Other noncurrent assets2111224
Total noncurrent assets:70717274768380
TOTAL ASSETS:402367385412453479234
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities100837974786756
Accounts payable957913119
Accrued liabilities91797264655647
Debt   6665
Other undisclosed current liabilities555    
Total current liabilities:104898479847361
Noncurrent Liabilities
Long-term debt and lease obligation22121521020520119613
Long-term debt, excluding current maturities210205199194189184 
Operating lease, liability10111111121213
Liabilities, other than long-term debt53221114
Deferred revenue51      
Other liabilities2221114
Total noncurrent liabilities:27421821220620219717
Total liabilities:37830729528528627078
Stockholders' equity
Stockholders' equity attributable to parent246090127167209156
Common stock0000000
Additional paid in capital1,1031,0931,0831,0721,0631,050947
Accumulated other comprehensive income (loss)(0)(0)0(0)(0)(0) 
Accumulated deficit(1,079)(1,033)(993)(945)(896)(841)(792)
Total stockholders' equity:246090127167209156
TOTAL LIABILITIES AND EQUITY:402367385412453479234

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues25201820251916
Cost of revenue(7)(5)(7)(8)(8)(8)(7)
Cost of goods and services sold(7)(5)(7)(6) (2)(1)
Gross profit:1815111216119
Operating expenses(54)(48)(53)(56)(66)(54)(55)
Operating loss:(36)(34)(43)(44)(50)(43)(46)
Nonoperating expense
(Other Nonoperating expense)
(5)(6)(6)(5)(5)(6)(1)
Interest and debt expense   (6)(6)(7) 
Other undisclosed loss from continuing operations before equity method investments, income taxes(27)      
Loss from continuing operations before equity method investments, income taxes:(67)(40)(48)(56)(61)(56)(47)
Other undisclosed income from continuing operations before income taxes27  667 
Loss from continuing operations before income taxes:(41)(40)(48)(49)(55)(49)(47)
Income tax expense (benefit)(5)  0   
Net loss available to common stockholders, diluted:(46)(40)(48)(49)(55)(49)(47)

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net loss:(46)(40)(48)(49)(55)(49)(47)
Other comprehensive loss     (0) 
Comprehensive loss:(46)(40)(48)(49)(55)(50)(47)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)(0)0(0)0  
Comprehensive loss, net of tax, attributable to parent:(46)(40)(48)(49)(55)(50)(47)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: